Mirum Pharmaceuticals, Inc. (MIRM)

87.95 +1.38 (+1.59%) USD  |  NASDAQ  |  Jan 12, 12:02
More

Mirum Pharmaceuticals Underperform Recommendations

Underperform Recommendations Chart

View Underperform Recommendations for MIRM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Underperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Underperform Recommendations Range, Past 5 Years

View Underperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Underperform Recommendations Benchmarks

View Underperform Recommendations Benchmarks
Start Trial
Pfizer Inc. Upgrade
XOMA Royalty Corp. Upgrade
Arcutis Biotherapeutics, Inc. Upgrade
Recursion Pharmaceuticals, Inc. Upgrade
Insmed, Inc. Upgrade